Molecular Modeling of Human CCR2 Receptor within POPC Lipid Bilayer

被引:0
|
作者
Ahmad Ebadi
Dara Dastan
Mojtaba Azami
Adibe Karimi
Nima Razzaghi-Asl
机构
[1] Hamadan University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy
[2] Hamadan University of Medical Sciences,Medicinal Plants and Natural Products Research Center
[3] Hamadan University of Medical Sciences,Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy
[4] Ardabil University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy
来源
Structural Chemistry | 2017年 / 28卷
关键词
Homology modeling; Docking; MD simulation; CCR2; Inflammation; INCB3344;
D O I
暂无
中图分类号
学科分类号
摘要
Chemokine receptor 2 (CCR2), a G-protein coupled receptor (GPCR), is a critical target for several inflammatory and autoimmune diseases. The main restriction on designing desirable antagonists against CCR2 is the lack of appropriate crystal structure for this target. In the absence of such experimental data, computational methods triggering structure prediction provide a cost-effective option. Homology modeling has been widely used to explore GPCR structure. Within the present contribution, homology modeling, molecular docking and molecular dynamics (MD) simulation were applied to construct a reliable model for CCR2. In the present contribution, we docked INCB3344, one of the most potent CCR2 inhibitors, into the active site of the CCR2 protein. Subsequently, we studied the dynamic behavior of INCB3344-CCR2 complex in the presence of lipid membrane. Moreover; a detailed molecular mechanism of INCB3344 action has been proposed. It was revealed that Tyr120, His121, Tyr259 and Glu291 formed H-bond interactions with INCB3344 while residues such as Trp98, His202, Thr203 and Thr173 participated in hydrophobic interactions. As a consequence, a reliable homology model of CCR2 could be successfully developed on the basis of CCR5 crystallographic structure. Finally it was found that binding of INCB3344 led to the structural changes in CCR2 that provided more interaction sites. Results of this study may be useful to design further CCR2 inhibiting structures with the aim of developing desirable therapeutic agents.
引用
收藏
页码:849 / 857
页数:8
相关论文
共 50 条
  • [21] Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists
    Cherney, Robert J.
    Mo, Ruowei
    Meyer, Dayton T.
    Pechulis, Anthony D.
    Guaciaro, Michael A.
    Lo, Yvonne C.
    Yang, Gengjie
    Miller, Persymphonie B.
    Scherle, Peggy A.
    Zhao, Qihong
    Cvijic, Mary Ellen
    Barrish, Joel C.
    Decicco, Carl P.
    Carter, Percy H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (19) : 6181 - 6184
  • [22] Molecular Dynamics Studies of Transportan 10 (Tp10) Interacting with a POPC Lipid Bilayer
    Dunkin, Christina M.
    Pokorny, Antje
    Almeida, Paulo F.
    Lee, Hee-Seung
    JOURNAL OF PHYSICAL CHEMISTRY B, 2011, 115 (05): : 1188 - 1198
  • [23] Functional expression of CCR2 by human fetal astrocytes
    Andjelkovic, AV
    Song, L
    Dzenko, KA
    Cong, H
    Pachter, JS
    JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 70 (02) : 219 - 231
  • [24] Molecular Dynamics simulations of mixture of POPC and PIP2 bilayer
    Orletsky, Nicholas
    Lyon, James
    Wiemken, Melissa
    Pandit, Sagar A.
    BIOPHYSICAL JOURNAL, 2009, 96 (03) : 460A - 460A
  • [25] Exploring a model of human chemokine receptor CCR2 in presence of TAK779: A membrane based molecular dynamics study
    Balupuri, Anand
    Sobhia, M. Elizabeth
    JOURNAL OF MOLECULAR STRUCTURE, 2014, 1063 : 131 - 138
  • [26] 3Dimensional molecular modeling and comparison of human and chimpanzee chemokine receptors CCR2, CCR3 and CX3CR1.
    Brinkworth, J. F.
    Ho, J. L.
    AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY, 2008, : 72 - 73
  • [27] Eotaxin: A CCR2 antagonist and a CCR5 agonist on human monocytes
    Ogilvie, P
    Bardi, G
    Loetscher, P
    Baggiolini, M
    Uguccioni, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 532 - 532
  • [28] Diaryl substituted pyrazoles as potent CCR2 receptor antagonists
    Pinkerton, Anthony B.
    Huang, Dehua
    Cube, Rowena V.
    Hutchinson, John H.
    Struthers, Mary
    Ayala, Julia M.
    Vicario, Pasquale P.
    Patel, Sima R.
    Wisniewski, Thomas
    DeMartino, Julie A.
    Vernier, Jean-Michel
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (03) : 807 - 813
  • [29] Chemokine receptor CCR2 involvement in skeletal muscle regeneration
    Warren, GL
    Hulderman, T
    Mishra, D
    Gao, X
    Millecchia, L
    O'Farrell, L
    Kuziel, WA
    Simeonova, PP
    FASEB JOURNAL, 2004, 18 (15): : 413 - +
  • [30] Phosphorylation of filamin A regulates chemokine receptor CCR2 recycling
    Pons, Monica
    Izquierdo, Ismael
    Andreu-Carbo, Mireia
    Garrido, Georgina
    Planaguma, Jesus
    Muriel, Olivia
    del Pozo, Miguel A.
    Geli, M. Isabel
    Aragay, Anna M.
    JOURNAL OF CELL SCIENCE, 2017, 130 (02) : 490 - 501